Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohan Lourie

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The Australian & New Zealand Journal of Obstetrics & Gynaecology|June 1, 2023
Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high-grade serous ovarian, fallopian tube, peritoneal cancer in an Australian contextArthur Samoylovich, Bronwyn Jennings, Catherine Shannon, et al.
Molecular Biology of the Cell|December 4, 2015
Epithelial Sel1L is required for the maintenance of intestinal homeostasisShengyi Sun, Rohan Lourie, Sara B Cohen, et al.
Gut|July 10, 2012
A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicityIulia Oancea, Chin Wen Png, Indrajit Das, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 10, 2025
Antigen presentation potential is variable among human ovarian tumour and syngeneic murine models and dictates pre-clinical outcomes of immunotherapyLouisa Alim, Siddharth Adityan, Rui Chen, et al.
Scientific Reports|June 29, 2016
High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22Max Gulhane, Lydia Murray, Rohan Lourie, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 23, 2026
Scalable Engineering of Bio-Manufactured Extracellular Vesicles for Selective Delivery in Ovarian Cancer Patient-Derived ModelsNihar Godbole, Andrew Lai, Alexander Quinn, et al.
Oncogene|August 21, 2019
MUC13 promotes the development of colitis-associated colorectal tumors via β-catenin activityYong Hua Sheng, Kuan Yau Wong, Inge Seim, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 9, 2025
Pathogenic OTUD3 Mutations Predispose to Ulcerative Colitis Due to Barrier DysfunctionRabina Giri, Minyi Lee, Graham W Magor, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 20, 2023
UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancerBrittney S Harrington, Rahul Kamdar, Franklin Ning, et al.
Molecular Pharmaceutics|August 27, 2021
Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian CancerYaowu He, Tashbib Khan, Thomas Kryza, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Australian & New Zealand Journal of Obstetrics & Gynaecology|June 1, 2023
Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high-grade serous ovarian, fallopian tube, peritoneal cancer in an Australian contextArthur Samoylovich, Bronwyn Jennings, Catherine Shannon, et al.
Molecular Biology of the Cell|December 4, 2015
Epithelial Sel1L is required for the maintenance of intestinal homeostasisShengyi Sun, Rohan Lourie, Sara B Cohen, et al.
Gut|July 10, 2012
A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicityIulia Oancea, Chin Wen Png, Indrajit Das, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 10, 2025
Antigen presentation potential is variable among human ovarian tumour and syngeneic murine models and dictates pre-clinical outcomes of immunotherapyLouisa Alim, Siddharth Adityan, Rui Chen, et al.
Scientific Reports|June 29, 2016
High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22Max Gulhane, Lydia Murray, Rohan Lourie, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 23, 2026
Scalable Engineering of Bio-Manufactured Extracellular Vesicles for Selective Delivery in Ovarian Cancer Patient-Derived ModelsNihar Godbole, Andrew Lai, Alexander Quinn, et al.
Oncogene|August 21, 2019
MUC13 promotes the development of colitis-associated colorectal tumors via β-catenin activityYong Hua Sheng, Kuan Yau Wong, Inge Seim, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 9, 2025
Pathogenic OTUD3 Mutations Predispose to Ulcerative Colitis Due to Barrier DysfunctionRabina Giri, Minyi Lee, Graham W Magor, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 20, 2023
UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancerBrittney S Harrington, Rahul Kamdar, Franklin Ning, et al.
Molecular Pharmaceutics|August 27, 2021
Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian CancerYaowu He, Tashbib Khan, Thomas Kryza, et al.
Pageof 5